Actualités sur Enterprises

Suivre
Abonner Enterprises
Filtre
  • 20.12.2013 – 23:09

    Government of Bermuda

    France Removes Bermuda from Tax Blacklist

    Hamilton, Bermuda (ots/PRNewswire) - The Hon. E.T. (Bob) Richards J.P., M.P., Minister of Finance, announced today that the French Ministry of Finance has informed the French Association of Financial Management (AFG) that "Jersey and Bermuda have been informed that they will be removed from the list for 2014, which means that the retaliation measures provided for by law will not be applied." The French Ministry of Finance ...

  • 20.12.2013 – 18:45

    Saxo Bank (Switzerland) SA

    Saxo Bank Announces New Board Members

    Hellerup, Denmark (ots/PRNewswire) - Saxo Bank, the online trading and investment specialist, is pleased to announce that Lone Fonss Schroder is appointed new Vice Chairman of the board and Jacob Polny, former alternate member, will continue on as a full member of the Board of Directors. Saxo Bank's new Board of Directors was approved by the shareholders at the extraordinary general meeting December 20th in Copenhagen. ...

  • 18.12.2013 – 10:01

    Takeda Pharmaceuticals Europe Ltd

    Takeda Launches New Subsidiary in Israel

    Zurich, Switzerland (ots/PRNewswire) - Demonstrates Takeda's commitment to bring new, innovative treatments to patients Takeda Pharmaceuticals International GmbH ("Takeda") today announced further expansion of its commercial platform with the establishment of its wholly-owned subsidiary in Israel. Together with Algeria, Ecuador, Peru, Singapore and Vietnam, Israel is the sixth sales entity Takeda has opened this year to ...

  • 17.12.2013 – 10:03

    Saxo Bank (Switzerland) SA

    Saxo Bank 10 Outrageous Predictions for 2014

    London (ots/PRNewswire) - Saxo Bank [http://www.saxobank.com ], the online multi-asset trading and investment specialist, today releases its annual set of 'Outrageous Predictions' for the year ahead. Although the probability of any one of the predictions coming true is low, they are deduced strategically by Saxo Bank analysts based on a feasible - if unlikely - series of market and political events. This year's ...

  • 12.12.2013 – 07:00

    Biosafe Group

    BIOSAFE targets Latin American expansion

    Eysins, Switzerland (ots) - Following the set-up of a Shanghai-based Chinese subsidiary and its recent expansion in India, Biosafe is demonstrating its firm commitment to emerging markets with the creation of a new subsidiary and the opening today of a new office covering the Latin American area. The new company, Biosafe do Brasil Participaçôes e Representações Ltda., based in the Vila Olímpia quarter of São Paulo ...

  • 09.12.2013 – 16:29

    Helsinn Healthcare SA

    Helsinn Group and Eisai announce FDA acceptance of New Drug Application for investigational compound netupitant 300 mg + palonosetron 0.50 mg (NEPA)

    Lugano, Switzerland/Woodcliff Lake, NJ, USA (ots) - Seeking indication for prevention of chemotherapy-induced nausea and vomiting Helsinn Group and Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) accepted for review the submission of the New Drug Application (NDA) for the investigational ...

  • 09.12.2013 – 07:25

    BNK Petroleum Inc.

    BNK Petroleum Inc. - Caney and Polish Update

    Camarillo, California (ots/PRNewswire) - BNK Petroleum Inc. (the "Company" or "BNK") , is providing an update on its Tishomingo Field, Caney oil shale operations in Oklahoma as well as its Polish shale gas project. Oklahoma - Tishomingo Field The Company's fifth Caney well, the Barnes 7-2H, was successfully fracture stimulated in 85 percent of the lateral and, while early in the flowback phase, has averaged approximately ...

  • 05.12.2013 – 09:47

    Sanofi Diabetes

    New Data Support Flexibility in Timing of Administration for Sanofi's Lyxumia®

    Paris (ots/PRNewswire) - - Similar glucose lowering effect when once-daily Lyxumia is administered before breakfast or the main meal - Sanofi announced today the results of a 24-week Phase IIIb clinical study showing that Lyxumia(R) (lixisenatide) met the primary endpoint of non-inferiority in blood sugar lowering (HbA1c) when administered either before breakfast or ...

  • 28.11.2013 – 07:32

    Eurazeo

    Moncler IPO: Eurazeo Plans to Sell Around 37% of its Interest in Moncler

    Milan (ots/PRNewswire) - Please click on the following link to read the press releases of Eurazeo and Moncler: http://www.multivu.com/mnr/64157-eurazeo-moncler-IPO-launch-of-the-offering Video: http://www.multivu.com/mnr/64157-eurazeo-moncler-IPO-launch-of-the-offering Contact: FOR ADDITIONAL INFORMATION PLEASE Moncler: Domenico Galluccio - Press Office, Tel. +39 02 ...